Annual Current Assets
$307.85 M
-$171.27 M-35.75%
31 December 2023
Summary:
Iovance Biotherapeutics annual total current assets is currently $307.85 million, with the most recent change of -$171.27 million (-35.75%) on 31 December 2023. During the last 3 years, it has fallen by -$328.25 million (-51.60%). IOVA annual current assets is now -51.60% below its all-time high of $636.10 million, reached on 31 December 2020.IOVA Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$498.58 M
+$16.32 M+3.38%
30 September 2024
Summary:
Iovance Biotherapeutics quarterly total current assets is currently $498.58 million, with the most recent change of +$16.32 million (+3.38%) on 30 September 2024. Over the past year, it has increased by +$115.99 million (+30.32%). IOVA quarterly current assets is now -36.30% below its all-time high of $782.65 million, reached on 30 June 2020.IOVA Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IOVA Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.8% | +30.3% |
| 3 y3 years | -51.6% | -14.5% |
| 5 y5 years | -35.2% | +35.7% |
IOVA Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -51.6% | at low | -21.8% | +81.4% |
| 5 y | 5 years | -51.6% | at low | -36.3% | +94.5% |
| alltime | all time | -51.6% | >+9999.0% | -36.3% | >+9999.0% |
Iovance Biotherapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $498.58 M(+3.4%) |
| June 2024 | - | $482.26 M(+25.1%) |
| Mar 2024 | - | $385.53 M(+25.2%) |
| Dec 2023 | $472.50 M(+155.6%) | $307.85 M(-19.5%) |
| Sept 2023 | - | $382.59 M(+39.2%) |
| June 2023 | - | $274.88 M(-56.9%) |
| Mar 2023 | - | $637.78 M(+33.1%) |
| Dec 2022 | $184.87 M(-31.4%) | $479.12 M(+29.5%) |
| Sept 2022 | - | $369.88 M(-14.3%) |
| June 2022 | - | $431.59 M(-11.9%) |
| Mar 2022 | - | $489.97 M(-3.5%) |
| Dec 2021 | $269.38 M(+103.5%) | $507.96 M(-12.9%) |
| Sept 2021 | - | $583.03 M(-12.5%) |
| June 2021 | - | $666.64 M(+10.1%) |
| Mar 2021 | - | $605.22 M(-4.9%) |
| Dec 2020 | $132.36 M(+370.0%) | $636.10 M(-12.1%) |
| Sept 2020 | - | $723.59 M(-7.5%) |
| June 2020 | - | $782.65 M(+205.3%) |
| Mar 2020 | - | $256.38 M(-19.0%) |
| Dec 2019 | $28.16 M(+417.0%) | $316.49 M(-13.8%) |
| Sept 2019 | - | $367.31 M(-10.6%) |
| June 2019 | - | $410.94 M(-7.6%) |
| Mar 2019 | - | $444.75 M(-6.4%) |
| Dec 2018 | $5.45 M(-10.5%) | $475.37 M(+78.8%) |
| Sept 2018 | - | $265.86 M(-5.0%) |
| June 2018 | - | $279.78 M(-7.6%) |
| Mar 2018 | - | $302.73 M(+102.8%) |
| Dec 2017 | $6.08 M(+156.2%) | $149.29 M(-12.9%) |
| Sept 2017 | - | $171.38 M(+26.5%) |
| June 2017 | - | $135.43 M(-11.2%) |
| Mar 2017 | - | $152.59 M(-10.0%) |
| Dec 2016 | $2.37 M | $169.51 M(-6.1%) |
| Sept 2016 | - | $180.56 M(-6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $192.35 M(+93.6%) |
| Mar 2016 | - | $99.36 M(-4.4%) |
| Dec 2015 | $1.68 M(+9.4%) | $103.98 M(-5.8%) |
| Sept 2015 | - | $110.39 M(-2.1%) |
| June 2015 | - | $112.71 M(+1.2%) |
| Mar 2015 | - | $111.41 M(+147.7%) |
| Dec 2014 | $1.53 M(+5410.8%) | $44.98 M(+161.0%) |
| Sept 2014 | - | $17.23 M(-7.0%) |
| June 2014 | - | $18.52 M(+2.5%) |
| Mar 2014 | - | $18.07 M(-9.0%) |
| Dec 2013 | $27.80 K(+25.8%) | $19.85 M(>+9900.0%) |
| Sept 2013 | - | $138.70 K(-76.0%) |
| June 2013 | - | $578.70 K(+7044.4%) |
| Mar 2013 | - | $8100.00(+11.0%) |
| Dec 2012 | $22.10 K(-50.1%) | $7300.00(+46.0%) |
| Sept 2012 | - | $5000.00(-79.5%) |
| June 2012 | - | $24.40 K(-28.2%) |
| Mar 2012 | - | $34.00 K(-93.5%) |
| Dec 2011 | $44.30 K(-72.3%) | $524.10 K(-84.1%) |
| Sept 2011 | - | $3.30 M(+911.4%) |
| June 2011 | - | $326.10 K(-58.6%) |
| Mar 2011 | - | $788.30 K(-39.4%) |
| Dec 2010 | $160.00 K(>+9900.0%) | $1.30 M(+62.4%) |
| Sept 2010 | - | $801.10 K(+273.6%) |
| June 2010 | - | $214.40 K(-32.3%) |
| Mar 2010 | - | $316.90 K(+3672.6%) |
| Dec 2009 | $1200.00(-53.8%) | $8400.00(+833.3%) |
| Sept 2009 | - | $900.00(-40.0%) |
| June 2009 | - | $1500.00(-11.8%) |
| Mar 2009 | - | $1700.00(-45.2%) |
| Dec 2008 | $2600.00 | $3100.00(-81.7%) |
| Sept 2008 | - | $16.90 K(-5.6%) |
| June 2008 | - | $17.90 K(-44.8%) |
| Mar 2008 | - | $32.40 K |
FAQ
- What is Iovance Biotherapeutics annual total current assets?
- What is the all time high annual current assets for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual current assets year-on-year change?
- What is Iovance Biotherapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly current assets year-on-year change?
What is Iovance Biotherapeutics annual total current assets?
The current annual current assets of IOVA is $307.85 M
What is the all time high annual current assets for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual total current assets is $636.10 M
What is Iovance Biotherapeutics annual current assets year-on-year change?
Over the past year, IOVA annual total current assets has changed by -$171.27 M (-35.75%)
What is Iovance Biotherapeutics quarterly total current assets?
The current quarterly current assets of IOVA is $498.58 M
What is the all time high quarterly current assets for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly total current assets is $782.65 M
What is Iovance Biotherapeutics quarterly current assets year-on-year change?
Over the past year, IOVA quarterly total current assets has changed by +$115.99 M (+30.32%)